Diabetes Clinical Trials in Tennessee

Showing 261-280 of 296 trials

The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study

NCT00547482

The main purpose of this research study is to investigate whether the TANTALUS II System is effective in improving glycemic (blood sugar) control in subjects who have type 2 diabetes (high blood sugar) and are overweight. The research will also evaluate the impact on weight loss and will study other health conditions related to obesity. This research study involves an experimental system. The experimental system is the TANTALUS System, which consists of the implantable portion that includes the implantable pulse generator (IPG) and three pairs of implantable leads. There are also three external parts (items that are used outside your body): the programmer, the charger, and the Patient Wand.

Type 2 Diabetes MellitusOverweight

MetaCure (USA), Inc.300 participantsStarted Sep 2007

La Jolla / San Diego, California, United States • Los Angeles, California, United States • Denver, Colorado, United States +7 more locations

COMPLETEDPHASE429 miles

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

NCT00654745

To determine if olmesartan plus amlodipine combination therapy alone and with hydrochlorothiazide will be safe and effective to reduce high blood pressure in hypertensive, type 2 diabetic subjects.

Type 2 DiabetesHypertension

Daiichi Sankyo207 participantsStarted May 2008

Los Angeles, California, United States • Sylmar, California, United States • Tustin, California, United States +18 more locations

The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

Diabetes Trials in Other Cities

Effect of Platelet Concentrate in Treatment of Diabetic Ulcers

Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients

Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

WelChol® and Insulin in Treating Patients With Type 2 Diabetes

Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone

DPBRN Blood Sugar Testing in Dental Patients

Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

Testing the Developmental Origins Hypothesis

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

A Study for Patients With Type 2 Diabetes Mellitus

Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus

Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty

GALLANT 6 Tesaglitazar vs. Pioglitazone

A Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokinetics of SK 0403

Mechanisms of Glucose Lowering Effect of Colesevelam HCl

Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes

Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment

Other Conditions in Tennessee